Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 2

Sponsor

Cancer Type

Breast 21Gastrointestinal 18Genitourinary 12Gynecologic 11CNS 8Other hematologic neoplasm 7Other solid neoplasm 4Lymphoid 4Head & Neck 3Sarcoma 2Dermatologic 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Other neoplasm 1Myeloid 1Endocrine 1Classical hematology 1

Conditions

Melanoma 2Sarcoma 1Melanoma, Cutaneous Malignant 1Hematologic Neoplasms 1Glioma 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 194aldesleukin 148Interleukin-2 110fludarabine phosphate 106trametinib 85Temozolomide 83Dacarbazine 81fludarabine 80dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Magnetic Resonance Spectroscopy 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Specimen Handling 47Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Genetic Testing × Dermatologic × Clear all
NCT01772771 2026-03-03

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

M.D. Anderson Cancer Center

Recruiting
12,000 enrolled
CNSDermatologicOther hematologic neoplasmSarcoma

Glioma, Melanoma, Sarcoma, Hematologic Neoplasms

NCT00450593 2013-08-12

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

National Cancer Institute (NCI)

Unknown
5,000 enrolled
Dermatologic

Melanoma, Cutaneous Malignant, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡